Related Experiment Video
Updated: Aug 5, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Determinants of Multidrug Resistance Among Gram-Positive Uropathogens in Central Portugal: A 5-Year Retrospective
Muhammad Adnan1, Patrícia Coelho2,3, Sónia Mateus2,3
1Health Research Institute, National Institute of Health, Islamabad, Pakistan, iss.it.
Abstract:
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide. Although Gram-negative bacteria predominate, Gram-positive cocci (GPC) are increasingly recognized as significant uropathogens. This retrospective study analyzed 655 patients with culture-confirmed GPC UTIs in a hospital in Central Portugal (2018-2022) to identify predictors of multidrug resistance (MDR). MDR was defined as resistance to three or more antimicrobial classes. The overall MDR prevalence was 83.7%, with Enterococcus spp. showing the highest MDR prevalence (98.2%). Multivariate analysis identified older age as an independent predictor of MDR, whereas Staphylococcus and Streptococcus species were associated with significantly lower odds compared to Enterococcus. A temporal increase in MDR risk was observed in 2021 and 2022. Despite the high overall resistance rates observed, oxazolidinones and cyclic lipopeptides retained near-complete activity against all GPC isolates, reinforcing their role as last-line therapeutic options.
Insights
Multidrug resistance (MDR) is high in Gram-positive cocci (GPC) causing urinary tract infections (UTIs), especially in older patients. Oxazolidinones and cyclic lipopeptides remain effective last-line treatments.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Urinary tract infections (UTIs) are common bacterial infections globally.
- Gram-negative bacteria are typical uropathogens, but Gram-positive cocci (GPC) are emerging threats.
- Multidrug resistance (MDR) in GPC UTIs requires urgent investigation.
Purpose of the Study:
- To determine the prevalence of MDR among GPC UTIs.
- To identify predictors of MDR in GPC UTIs.
- To assess antimicrobial resistance trends and effective last-line therapies.
Main Methods:
- Retrospective analysis of 655 patients with culture-confirmed GPC UTIs.
- Data collected from a Central Portugal hospital between 2018 and 2022.
- Multivariate analysis to identify MDR predictors and temporal trends.
Main Results:
- Overall MDR prevalence was 83.7%, with 98.2% MDR in Enterococcus spp.
- Older age was an independent predictor of MDR.
- Staphylococcus and Streptococcus species showed lower MDR odds than Enterococcus.
- MDR risk increased in 2021-2022.
- Oxazolidinones and cyclic lipopeptides maintained high activity.
Conclusions:
- GPC UTIs exhibit high and increasing MDR rates.
- Older age and Enterococcus species are key risk factors for MDR.
- Last-line antibiotics like oxazolidinones and cyclic lipopeptides are crucial for MDR GPC UTIs.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations